J Korean Neurosurg Soc.  2018 Jul;61(4):494-502. 10.3340/jkns.2017.0216.

The Effect of Postoperative Use of Teriparatide Reducing Screw Loosening in Osteoporotic Patients

Affiliations
  • 1Department of Neurosurgery, Chung-Ang University Hospital, Seoul, Korea. nspsw@cau.ac.kr

Abstract


OBJECTIVE
The loosening of pedicle screws (PS) is one of the frequent problems of spinal surgery in the patients with osteoporosis. Previous studies had revealed that intermittent injection of teriparatide could reduce PS loosening by improving bone mass and quality when their patients took parathyroid hormone for a considerable duration before surgery. However, although the teriparatide is usually used after spine surgery in most clinical situations, there was no report on the efficacy of teriparatide treatment started after spine surgery. The purpose of this retrospective study was to examine the efficacy of teriparatide treatment started immediately after lumbar spinal surgery to prevent pedicle screw loosening in patients with osteoporosis.
METHODS
We included 84 patients with osteoporosis and degenerative lumbar disease who underwent transforaminal interbody fusion and PS fixation and received parathyroid hormone or bisphosphonate (BP) postoperatively. They were divided into teriparatide group (daily injection of 20 μg of teriparatide for 6 months, 33 patients, 172 screws) and BP group (weekly oral administration of 35 mg of risedronate, 51 patients, 262 screws). Both groups received calcium (500 mg/day) and cholecalciferol (1000 IU/day) together. The screw loosening was evaluated with simple radiographic exams at 6 and 12 months after the surgery. We counted the number of patients with PS loosening and the number of loosened PS, and compared them between the two groups. Clinical outcomes were evaluated using visual analog scale (VAS) and Oswestry disability index (ODI) preoperatively, and at 12 months after surgery.
RESULTS
There was no significant difference in the age, sex, diabetes, smoking, bone mineral density, body mass index, and the number of fusion levels between the two groups. The number of PS loosening within 6 months after surgery did not show a significant difference between the teriparatide group (6.9%, 12/172) and the BP group (6.8%, 18/272). However, during 6-12 months after surgery, it was significantly lower in the teriparatide group (2.3%, 4/172) than the BP group (9.2%, 24/272) (p < 0.05). There was no significant difference in the number of patients showing PS loosening between the teriparatide and BP groups. The teriparatide group showed a significantly higher degree of improvement of the bone mineral density (T-score) than that of BP group (p < 0.05). There was no significant difference in the pre- and post-operative VAS and ODI between the groups.
CONCLUSION
Our data suggest that the teriparatide treatment starting immediately after lumbar spinal fusion surgery could reduce PS loosening compared to BP.

Keyword

Parathyroid hormone; Teriparatide; Spinal fusion

MeSH Terms

Administration, Oral
Body Mass Index
Bone Density
Calcium
Cholecalciferol
Humans
Osteoporosis
Parathyroid Hormone
Pedicle Screws
Retrospective Studies
Risedronate Sodium
Smoke
Smoking
Spinal Fusion
Spine
Teriparatide*
Visual Analog Scale
Calcium
Cholecalciferol
Parathyroid Hormone
Risedronate Sodium
Smoke
Teriparatide

Cited by  1 articles

Therapeutic Effect of Teriparatide for Osteoporotic Thoracolumbar Burst Fracture in Elderly Female Patients
Dongwoo Yu, Sungho Kim, Ikchan Jeon
J Korean Neurosurg Soc. 2020;63(6):794-805.    doi: 10.3340/jkns.2020.0110.


Reference

References

1. Abe Y, Takahata M, Ito M, Irie K, Abumi K, Minami A. Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model. Bone. 41:775–785. 2007.
Article
2. Arlot M, Meunier PJ, Boivin G, Haddock L, Tamayo J, Correa‐Rotter R, et al. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res. 20:1244–1253. 2005.
Article
3. Bothmann M, Kast E, Boldt GJ, Oberle J. Dynesys fixation for lumbar spine degeneration. Neurosurg Rev. 31:189–196. 2008.
Article
4. Bransford R, Goergens E, Briody J, Amanat N, Cree A, Little D. Effect of zoledronic acid in an L6-L7 rabbit spine fusion model. Eur Spine J. 16:557–562. 2007.
Article
5. Chin DK, Park JY, Yoon YS, Kuh SU, Jin BH, Kim KS, et al. Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease. Osteoporos Int. 18:1219–1224. 2007.
Article
6. Cook SD, Salkeld SL, Whitecloud TS 3rd, Barbera J. Biomechanical evaluation and preliminary clinical experience with an expansive pedicle screw design. J Spinal Diso. 13:230–236. 2000.
Article
7. Dakhil-Jerew F, Jadeja H, Cohen A, Shepperd JA. Inter-observer reliability of detecting Dynesys pedicle screw using plain X-rays: a study on 50 post-operative patients. Eur Spine J. 18:1486–1493. 2009.
Article
8. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res. 16:1846–1853. 2001.
Article
9. DeWald CJ, Stanley T. Instrumentation-related complications of multilevel fusions for adult spinal deformity patients over age 65: surgical considerations and treatment options in patients with poor bone quality. Spine (Phila Pa 1976). 31(19 Suppl):S144–S151. 2006.
10. Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A. 96:133–138. 1999.
Article
11. Flahiff CM, Gober GA, Nicholas RW. Pullout strength of fixation screws from polymethylmethacrylate bone cement. Biomaterials. 16:533–536. 1995.
Article
12. Gaines RW Jr. The use of pedicle-screw internal fixation for the operative treatment of spinal disorders. J Bone Joint Surg Am. 82:1458–1458. 2000.
Article
13. Graeff C, Timm W, Nickelsen TN, Farrerons J, Marín F, Barker C, et al. Monitoring teriparatide‐associated changes in vertebral microstructure by high‐resolution CT in vivo: results from the EUROFORS study. J Bone Miner Res. 22:1426–1433. 2007.
Article
14. Halvorson TL, Kelley LA, Thomas KA, Whitecloud TS 3rd, Cook SD. Effects of bone mineral density on pedicle screw fixation. Spine (Phila Pa 1976). 19:2415–2420. 1994.
Article
15. Heinemann DF. Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide. Geriatrics. 55:31–36. quiz 39. 2000.
16. Inoue G, Ueno M, Nakazawa T, Imura T, Saito W, Uchida K, et al. Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis: Clinical article. J Neurosurg Spine. 21:425–431. 2014.
Article
17. Jakob F, Oertel H, Langdahl B, Ljunggren O, Barrett A, Karras D, et al. Effects of teriparatide in postmenopausal women with osteoporosis pretreated with bisphosphonates: 36-month results from the European Forsteo Observational Study. Eur J Endocrinol. 166:87–97. 2012.
Article
18. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res. 18:1932–1941. 2003.
Article
19. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 359:1929–1936. 2002.
Article
20. Keaveny TM, Donley DW, Hoffmann PF, Mitlak BH, Glass EV, San Martin JA. Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res. 22:149–157. 2007.
Article
21. Lee JH, Lee JH, Park JW, Shin YH. The insertional torque of a pedicle screw has a positive correlation with bone mineral density in posterior lumbar pedicle screw fixation. J Bone Joint Surg Br. 94:93–97. 2012.
Article
22. Lehman RA Jr, Dmitriev AE, Cardoso MJ, Helgeson MD, Christensen CL, Raymond JW, et al. Effect of teriparatide [rhPTH(1, 34)] and calcitonin on intertransverse process fusion in a rabbit model. Spine (Phila Pa 1976). 35:146–152. 2010.
Article
23. Lehman RA Jr, Kang DG, Wagner SC. Management of osteoporosis in spine surgery. J Am Acad Orthop Surg. 23:253–263. 2015.
Article
24. Lehman RA Jr, Kuklo TR, Freedman BA, Cowart JR, Mense MG, Riew KD. The effect of alendronate sodium on spinal fusion: a rabbit model. Spine J. 4:36–43. 2004.
Article
25. Lei W, Wu Z. Biomechanical evaluation of an expansive pedicle screw in calf vertebrae. Eur Spine J. 15:321–326. 2006.
Article
26. Luk KD, Chen L, Lu WW. A stronger bicortical sacral pedicle screw fixation through the s1 endplate: an in vitro cyclic loading and pull-out force evaluation. Spine (Phila Pa 1976). 30:525–529. 2005.
Article
27. McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med. 165:1762–1768. 2005.
Article
28. Moore DC, Maitra RS, Farjo LA, Graziano GP, Goldstein SA. Restoration of pedicle screw fixation with an in situ setting calcium phosphate cement. Spine (Phila Pa 1976). 22:1696–1705. 1997.
Article
29. Murad MH, Drake MT, Mullan RJ, Mauck KF, Stuart LM, Lane MA, et al. Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 97:1871–1880. 2012.
Article
30. Nagahama K, Kanayama M, Togawa D, Hashimoto T, Minami A. Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial: clinical article. J Neurosurg Spine. 14:500–507. 2011.
Article
31. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 344:1434–1441. 2001.
Article
32. O’Loughlin PF, Cunningham ME, Bukata SV, Tomin E, Poynton AR, Doty SB, et al. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine (Phila Pa 1976). 34:121–130. 2009.
Article
33. Ohtori S, Inoue G, Orita S, Yamauchi K, Eguchi Y, Ochiai N, et al. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. Spine (Phila Pa 1976). 37:E1464–E1468. 2012.
34. Ohtori S, Inoue G, Orita S, Yamauchi K, Eguchi Y, Ochiai N, et al. Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine (Phila Pa 1976). 38:E487–E492. 2013.
Article
35. Okuyama K, Abe E, Suzuki T, Tamura Y, Chiba M, Sato K. Can insertional torque predict screw loosening and related failures? An in vivo study of pedicle screw fixation augmenting posterior lumbar interbody fusion. Spine (Phila Pa 1976). 25:858–864. 2000.
36. Ozawa T, Takahashi K, Yamagata M, Ohtori S, Aoki Y, Saito T, et al. Insertional torque of the lumbar pedicle screw during surgery. J Orthop Sci. 10:133–136. 2005.
Article
37. Pfeiffer M, Gilbertson LG, Goel VK, Griss P, Keller JC, Ryken TC, et al. Effect of specimen fixation method on pullout tests of pedicle screws. Spine (Phila Pa 1976). 21:1037–1044. 1996.
Article
38. Quon JA, Sobolev BG, Levy AR, Fisher CG, Bishop PB, Kopec JA, et al. The effect of waiting time on pain intensity after elective surgical lumbar discectomy. Spine J. 13:1736–1748. 2013.
Article
39. Rajzbaum G, Grados F, Evans D, Liu-Leage S, Petto H, Augendre-Ferrante B. Treatment persistence and changes in fracture risk, back pain, and quality of life amongst patients treated with teriparatide in routine clinical care in France: results from the European Forsteo Observational Study. Joint Bone Spine. 81:69–75. 2014.
Article
40. Sandén B, Olerud C, Petrén-Mallmin M, Johansson C, Larsson S. The significance of radiolucent zones surrounding pedicle screws. Definition of screw loosening in spinal instrumentation. J Bone Joint Surg Br. 86:457–461. 2004.
41. Sawakami K, Yamazaki A, Ishikawa S, Ito T, Watanabe K, Endo N. Polymethylmethacrylate augmentation of pedicle screws increases the initial fixation in osteoporotic spine patients. J Spinal Disord Tech. 25:E28–E35. 2012.
Article
42. Tu CW, Huang KF, Hsu HT, Li HY, Yang SS, Chen YC. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis. J Surg Res. 192:112–116. 2014.
Article
43. Wray S, Mimran R, Vadapalli S, Shetye SS, McGilvray KC, Puttlitz CM. Pedicle screw placement in the lumbar spine: effect of trajectory and screw design on acute biomechanical purchase. J Neurosurg Spine. 22:503–510. 2015.
Article
44. Wu J, Huang W, Tsai H, Ko C, Wu C, Tu T, et al. Pedicle screw loosening in dynamic stabilization: incidence, risk, and outcome in 126 patients. Neurosurg Focus. 31:E9. 2011.
Article
45. Wu ZX, Gong FT, Liu L, Ma ZS, Zhang Y, Zhao X, et al. A comparative study on screw loosening in osteoporotic lumbar spine fusion between expandable and conventional pedicle screws. Arch Orthop Trauma Surg. 132:471–476. 2012.
Article
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr